FindTrial
Sign In

An Open-label, Long-term Administration Study of S-8117 in Patients with Chronic Pain

An Open-label, Long-term Administration Study of S-8117 in Patients with Chronic Pain

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222035
Enrollment
Unknown
Registered
2013-03-07
Start date
2013-03-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain

Interventions

investigational material(s) Generic name etc : S-8117 INN of investigational material : Oxycodone hydrochloride hydrate Therapeutic category code : 811 Opium alkaloids preparations Dosage and Administ

Sponsors

SHIONOGI & CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with pain for at least 12 weeks, and the pain is diagnosed as chronic pain such as osteoarthritis, diabetic neuropathy, or postherpetic neuralgia. And etc.

Exclusion criteria

Exclusion criteria: Patients with previous or present allergy or hypersensitivity to opium alkaloids. Patients who participated in a clinical trial of S-8117 previously and received S-8117. And etc.

Design outcomes

Primary

MeasureTime frame
Insufficient analgesic response rate—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026